These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3063326)

  • 21. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
    Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
    Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory control in predicting clinical efficacy of T cell-depletion procedures used for prevention of graft-versus-host disease: importance of limiting dilution analysis.
    Marciniak E; Romond EH; Thompson JS; Henslee PJ
    Bone Marrow Transplant; 1988 Nov; 3(6):589-98. PubMed ID: 3063328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results.
    Soiffer RJ; Ritz J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S7-10. PubMed ID: 8124262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depletion of T-lymphocytes in donor marrow with pan-T monoclonal antibodies and complement for prevention of acute graft-versus-host disease: a pilot study on 29 patients.
    Herve P
    J Natl Cancer Inst; 1986 Jun; 76(6):1311-6. PubMed ID: 3520074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure.
    Mehta J; Powles R; Singhal S; Matthey F; Hamblin M; Middleton G; Prendiville J; Glynne P; Zomas A; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 May; 17(5):881-3. PubMed ID: 8733715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo depletion of T cells.
    Arnold R; Bunjes D; Wiesneth M; Hertenstein B; Theobald M; Heimpel H; Hale G; Waldmann H
    Bone Marrow Transplant; 1993; 12 Suppl 3():S11-2. PubMed ID: 8124250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.
    Apperley JF; Jones L; Hale G; Waldmann H; Hows J; Rombos Y; Tsatalas C; Marcus RE; Goolden AW; Gordon-Smith EC
    Bone Marrow Transplant; 1986 May; 1(1):53-66. PubMed ID: 3332120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell and NK cell mediated graft-versus-leukaemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukaemia.
    Jiang YZ; Cullis JO; Kanfer EJ; Goldman JM; Barrett AJ
    Bone Marrow Transplant; 1993 Feb; 11(2):133-8. PubMed ID: 8435662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engraftment of T-cell-depleted rabbit bone marrow.
    Gratwohl A; Baldomero H; Nissen C; Speck B
    Acta Haematol; 1987; 77(4):208-14. PubMed ID: 3115031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interstitial pneumonitis after hyperfractionated total body irradiation in HLA-matched T-depleted bone marrow transplantation.
    Latini P; Aristei C; Aversa F; Checcaglini F; Maranzano E; Panizza BM; Perrucci E; Carotti A; Martelli MF
    Int J Radiat Oncol Biol Phys; 1992; 23(2):401-5. PubMed ID: 1587763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell depletion for bone marrow transplantation: effects on graft rejection, graft-versus-host disease, graft-versus-leukemia, and survival.
    Champlin RE
    Cancer Treat Res; 1990; 50():99-111. PubMed ID: 1976361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow transplantation for haemopoietic neoplasia. Evaluation of a new approach to T cell depletion.
    Speck B; Dazzi H; Gratwohl A; Tichelli A; Nissen C
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():56-7. PubMed ID: 2627624
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful adoptive immunotherapy for relapse of AML 9 years after T-cell-depleted BMT.
    Bertz H; Kunzman R; Bunjes D; Finke J
    Br J Haematol; 1998 Nov; 103(2):563-4. PubMed ID: 9827936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of T-cell depletion for bone marrow transplantation.
    Blaise D; Gravis G; Maraninchi D
    Lancet; 1993 Jan; 341(8836):51-2. PubMed ID: 8093295
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of flow microfluorometry in bone marrow transplantation.
    Martin PJ; Hansen JA; Thomas ED
    Ann N Y Acad Sci; 1984; 428():14-25. PubMed ID: 6378022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.